Allogene Therapeutics Inc (ALLO)
3.07
+0.10
(+3.37%)
USD |
NASDAQ |
May 03, 16:00
3.08
+0.01
(+0.33%)
Pre-Market: 08:25
Allogene Therapeutics EBITDA Margin (Quarterly)
EBITDA Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
Date | Value |
---|---|
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
EBITDA Margin Definition
EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.